Pharmagreen Biotech Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2018 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Pharmagreen Biotech Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2018 to Q2 2023.
  • Pharmagreen Biotech Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2023 was -$163K, a 165% decline year-over-year.
  • Pharmagreen Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$876K, a 80.7% increase from 2021.
  • Pharmagreen Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$4.53M, a 82.6% decline from 2020.
  • Pharmagreen Biotech Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$2.48M, a 223% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$163K -$415K -165% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q4 2022 -$934K -$39.4K -$58.1K -310% Oct 1, 2022 Dec 31, 2022 10-Q 2023-05-19
Q3 2022 -$876K -$110K +$721K +86.7% Jul 1, 2022 Sep 30, 2022 10-K 2023-01-17
Q2 2022 -$1.6M $252K +$394K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$1.99M -$1.04M +$2.11M +67% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-19
Q4 2021 -$4.1M $18.7K +$436K Oct 1, 2021 Dec 31, 2021 10-Q 2023-08-14
Q3 2021 -$4.53M -$831K +$80.8K +8.85% Jul 1, 2021 Sep 30, 2021 10-K 2023-01-17
Q2 2021 -$4.61M -$142K +$1.22M +89.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-17
Q1 2021 -$5.83M -$3.14M -$3.14M -86512% Jan 1, 2021 Mar 31, 2021 10-Q 2022-08-17
Q4 2020 -$2.69M -$417K -$211K -102% Oct 1, 2020 Dec 31, 2020 10-Q 2022-08-17
Q3 2020 -$2.48M -$912K -$688K -307% Jul 1, 2020 Sep 30, 2020 10-K 2021-12-29
Q2 2020 -$1.79M -$1.36M -$1.3M -2275% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-18
Q1 2020 -$491K -$3.63K +$89.5K +96.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-08-18
Q4 2019 -$581K -$206K +$187K +47.6% Oct 1, 2019 Dec 31, 2019 10-Q 2021-08-18
Q3 2019 -$768K -$224K Jul 1, 2019 Sep 30, 2019 10-K 2021-01-08
Q2 2019 -$57.3K +$272K +82.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-19
Q1 2019 -$93.1K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-19
Q4 2018 -$393K Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-18
Q2 2018 -$329K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.